Hiromi Nagashima

Dr. Hiromi Nagashima

orcid

Research Focus & Metrics

Academic Career Length

16Years (2011-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
25 October 2011 in Journal of Medical Case Reports
Verified
Journal Article
Open access
PDF file
YNYutaka Nakamura
Yutaka Nakamura
YUYu Utsumi
Yu Utsumi
NSNaomi Suzuki
Naomi Suzuki
YNYoshio Nakajima
Yoshio Nakajima
OMOkinori Murata
Okinori Murata
KYKohei Yamauchi
Kohei Yamauchi
Scedosporium apiospermum is increasingly recognized as a cause of localized and disseminated mycotic infections in near-drowning victims.

26 February 2021 in Medicina
Verified
Journal Article
Open access
PDF file
HSHirotaka Saikawa
Hirotaka Saikawa
HNHiromi Nagashima
Hiromi Nagashima
KCKatsuya Cho
Katsuya Cho
RCRyosuke Chiba
Ryosuke Chiba
KSKoichiro Sera
Koichiro Sera
MMMakoto Maemondo
Makoto Maemondo
Background and Objectives: This study aimed to observe the relationship between trace element concentrations in lung tissue from lung non-small cell lung carcinoma (NSCLC) patients and prognosis. Materials and Methods: The concentrations of various trace elements in the lung tissues were measured by a particle-induced X-ray emission (PIXE) system, and the results were analyzed for statistical significance. Eight essential trace elements, Cr, Mn, Fe, Co, Cu, Zn, Se, and Mo, were analyzed. We investigated the relationship between trace element concentrations and disease-free survival (DFS) and overall survival (OS) in NSCLC patients. Results: A total of 129 NSCLC patients and 20 control patients were included in this study. As for DFS, Co was the only element that showed a significant difference, and the high Co group had better DFS (HR: 0.352, 95% CI = 0.128–0.97). No significant difference was observed for Cr, Mn, Fe, Se, or Mo, but DFS tended to be better in the high trace element group. No significant difference was observed for Cu and Zn, but DFS tended to be good in the low trace element group. As for OS, Cr was the only element that showed a significant difference, and the high Cr element group had better OS (HR: 0.477, 95% CI = 0.128–0.97). Conclusions: This study suggests that the prognosis is good in lung cancer cases with high intratumoral concentrations of Co and Cr. The dynamics of trace elements in body and in tumor tissue have not been well established, and we consider that more research is necessary in the future.

22 January 2025 in Water Research
Verified
Journal Article
Open access
YGYalan Gan
Yalan Gan
FKFutoshi Kurisu
Futoshi Kurisu
DSDai Simazaki
Dai Simazaki
MYMitsunori YOSHIDA
Mitsunori YOSHIDA
HFHanako Fukano
Hanako Fukano
IKIkuro Kasuga
Ikuro Kasuga
The health burden of waterborne nontuberculous mycobacteria (NTM) is a rising concern. While the water supply systems can serve as a potential reservoir for NTM, their abundance, diversity, and transmission pathways remain unknown. This study aimed to characterize the prevalence and regrowth of NTM in building water supply system in a hospital where many M. abscessus were isolated from patients. The depletion of residual chlorine after stagnation and supply of warm water at the point of use promoted significant microbial regrowth, including NTM, in the hospital. The absolute abundance of Mycobacterium spp. 16S rRNA genes in tap water and shower water samples increased to approximately 104 copies/mL, while it was below the quantification limit in the finished water from a drinking water treatment plant. Amplicon sequencing of NTM-specific hsp65 genes revealed that M. abscessus was prevalent in all samples, while the dominant NTM species varied depending on locations even in the same building. The presence of M. abscessus in water suggested the possibility of waterborne transmission in the hospital. M. abscessus was frequently isolated from tap water, shower water, and shower biofilms. These isolates demonstrated high clonality and were closely affiliated with the ABS-GL4 cluster of M. abscessus subsp. abscessus. Even though the automatic mixing equipment at the point of use was replaced with new one, the settlement and growth of NTM were reproducibly observed, suggesting mixing equipment as a hotspot for NTM proliferation. Additional interventions including water quality control are required as the hospital water supply system is a hot spot for NTM regrowth.

24 August 2023 in Cancers
Verified
Journal Article
Open access
PDF file
KWKana Watanabe
Kana Watanabe
RSRyota Saito
Ryota Saito
EMEisaku Miyauchi
Eisaku Miyauchi
HNHiromi Nagashima
Hiromi Nagashima
ANAtsushi Nakamura
Atsushi Nakamura
MMMakoto Maemondo
Makoto Maemondo
Background: Osimertinib was first approved for the treatment of non-small cell lung cancer (NSCLC) in patients who have developed the epidermal growth factor receptor (EGFR) T790M mutation after treatment with EGFR tyrosine kinase inhibitors (TKIs). We routinely evaluated the plasma of NSCLC patients with the T790M mutation to more rapidly detect an increase in disease activity and resistance to treatment. Methods: Eligible patients received osimertinib after resistance to the first- or second-generation of EGFR-TKIs in NSCLC harboring T790M mutation detectable in tumor tissue or plasma. Plasma samples were collected every 8 weeks during osimertinib treatment. The plasma analysis was performed using an improved PNA-LNA PCR clamp method. We tested samples for a resistance mechanism, including EGFR-activating, T790M, and C797S mutations, and assessed the association between the mutations and osimertinib treatment. Results: Of the 60 patients enrolled in the study, 58 were eligible for this analysis. In plasma collected before osimertinib treatment, activating mutations were detected in 47 of 58 patients (81.0%) and T790M was detected in 44 patients (75.9%). Activating mutations were cleared in 60.9% (28/46) and T790M was cleared in 93.0% (40/43). Of these, 71.4% (20/28) of activating mutations and 87.5% (35/40) of T790M mutation were cleared within 8 weeks of treatment. The total response rate (RR) was 53.4% (31/58). The median duration of treatment was 259 days, with a trend toward longer treatment duration in patients who experienced the clearance of activating mutations with osimertinib. At the time of disease progression during osimertinib treatment, C797S was detected in 3 of 37 patients (8.1%). Conclusion: Plasma EGFR mutation analysis was effective in predicting the effect of osimertinib treatment.

5 March 2016 in Journal of Pharmaceutical Health Care and Sciences
Verified
Journal Article
Open access
PDF file
JSJunya Sato
Junya Sato
NMNaoto Morikawa
Naoto Morikawa
HNHiroo Nitanai
Hiroo Nitanai
HNHiromi Nagashima
Hiromi Nagashima
SNSatoru Nihei
Satoru Nihei
KKKenzo Kudo
Kenzo Kudo
Cisplatin (CDDP) is used as a key anticancer drug for solid cancers, including lung cancer. However, a large quantity of fluid replacement is required to prevent renal dysfunction. This requirement have made outpatient chemotherapies including CDDP administration less popular among the available therapeutic options. We designed a short-term hydration regimen combined with oral rehydration solution (ORS) that has a supplementary water ability equivalent to intravenous electrolyte maintenance infusion and investigated its safety and feasibility in the CDDP including chemotherapy. The subjects received chemotherapy including CDDP administration (60–80 mg/m2) for untreated lung cancer were recruited. The intravenous hydration was infused at around 2000 mL on Day 1, and patients drank ORS at a dose of 1000 mL/day for 3 days. Any renal dysfunction, gastrointestinal symptoms or other tolerability variables pertaining to the remaining three cycles of this regimen were analyzed in the patients who were able to continue treatment after the second cycle. The majority (29/35, 82.9 %) of patients completed intake of ORS for 3 days. The mean ± standard deviation of patient body-surface area-adjusted estimated glomerular filtration rate (eGFR), serum creatinine (sCre) and urea nitrogen from the initial therapy to 1 month after the last administration changed from 79.8 ± 11.7–67.0 ± 16.9 mL/min (p = 0.15), 0.70 ± 0.13–0.85 ± 0.27 mg/dL (p = 0.02), and 14.3 ± 3.8–17.1 ± 5.4 mg/dL (p = 0.09), respectively. The CTCAE ver 4.0 grades 1 or 2 adverse events pertaining to renal function after the last administration were 2 (5.7 %)/2 (5.7 %) patients assessed by sCre, and 14 (40.0 %)/12 (34.3 %) patients assessed by eGFR, respectively. There was no patient with ≥3 grade renal dysfunction based on either evaluation. Based on the results of this study, supplementary use of the ORS as a method of short-term hydration may be a feasible regimen for shortening infusion times and improving safety for those undergoing chemotherapy including CDDP administration.

1 June 2016 in Pulmonary Pharmacology & Therapeutics
Verified
Journal Article
Closed access
RSRioto Suzuki
Rioto Suzuki
YNYutaka Nakamura
Yutaka Nakamura
SCShinji Chiba
Shinji Chiba
TMTomoki Mizuno
Tomoki Mizuno
KAKazuyuki Abe
Kazuyuki Abe
KYKohei Yamauchi
Kohei Yamauchi